openPR Logo
Press release

Vaccine CDMO Market: Key Developments in Biopharmaceutical Manufacturing to 2030

03-31-2025 11:21 AM CET | Health & Medicine

Press release from: Medi-Tech Insights

Vaccine CDMO Market: Key Developments in Biopharmaceutical

The global lentiviral vector CDMO market is set to witness a growth rate of 8% in the next 5 years. Growing demand for gene and cell therapies; expanding pipeline of gene therapy products; technological advancements in lentiviral vector production; growing investments in biopharmaceutical R&D and increasing strategic partnerships and collaborations are some of the key factors driving the lentiviral vector CDMO market.

Lentiviral vector contract development and manufacturing organization (CDMO) specializes in producing lentiviral vectors, critical for delivering genetic material in advanced therapies like CAR-T and gene therapies. These organizations offer comprehensive services, including vector design, process development, analytical testing, and large-scale GMP manufacturing. Leveraging state-of-the-art facilities and technical expertise, CDMOs ensure high-quality, regulatory-compliant production, helping biotech and pharmaceutical companies overcome manufacturing challenges. By partnering with CDMOs, companies can accelerate clinical trials, reduce time-to-market, and focus on research and innovation. Lentiviral Vector CDMOs play a vital role in advancing personalized medicine and addressing the growing demand for gene and cell therapies.

Get the latest market trends growth report - download your free sample
https://meditechinsights.com/vaccine-cdmo-market/request-sample/

Growing demand for gene and cell therapies to propel market demand

The growing demand for gene and cell therapies is a key driver of the lentiviral vector CDMO market growth. These therapies, such as CAR-T and gene editing, rely on lentiviral vectors to deliver genetic material into target cells. With an increasing approvals and clinical trials for gene and cell therapies, the need for scalable, high-quality vector manufacturing has surged. CDMOs offer advanced technologies, regulatory expertise, and large-scale production capabilities, enabling biotech and pharma companies to meet rising demands. This trend accelerates the development and commercialization of innovative therapies, solidifying the role of lentiviral vector CDMOs in the expanding biopharma industry.

Technological advancements in lentiviral vector production are driving the market growth

Technological advancements in lentiviral vector production are driving the lentiviral vector CDMO market by improving manufacturing efficiency, scalability, and cost-effectiveness. Innovations such as suspension-based production systems, optimized upstream and downstream processes, and automation enable higher yields and consistent quality. Advances in vector engineering, including self-inactivating and pseudotyped vectors, enhance safety and transduction efficiency, making them more suitable for clinical applications. These improvements attract biopharma companies seeking reliable, cutting-edge solutions for gene and cell therapies. By adopting these technologies, CDMOs can meet growing demand, reduce production timelines, and strengthen their position in the competitive biopharma landscape.

Competitive Landscape Analysis

The global lentiviral vector CDMO market is marked by the presence of established and emerging market players such as Thermo Fisher Scientific Inc., Catalent, Inc, ProBio, Revvity, Charles River Laboratories, Lonza, Oxford Biomedica PLC, Wuxi Advanced Therapies, ProBioGen AG, and AGC Biologics; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Gain valuable insights for better business strategies: https://meditechinsights.com/vaccine-cdmo-market/

Market Segmentation

This report by Medi-Tech Insights provides the size of the global lentiviral vector CDMO market at the regional- and country-level from 2023 to 2030. The report further segments the market based on phase, application, end user.

Market Size & Forecast (2023-2030), By Phase, USD Million

Preclinical
Clinical
Commercial

Market Size & Forecast (2023-2030), By Application, USD Million

Gene Therapy
Cell Therapy
Vaccines
Others

Market Size & Forecast (2023-2030), By End User, USD Million

Pharmaceutical Companies
Biotech Companies
Other End Users

Market Size & Forecast (2023-2030), By Region, USD Million

North America
Europe
Rest of Europe
Latin America
Middle East & Africa

Find more related report:

Vaccines Market: https://meditechinsights.com/global-vaccines-market/

Vaccine Storage Equipment Market: https://meditechinsights.com/global-vaccine-storage-equipment-market/

Lentiviral Vector CDMO Market: https://meditechinsights.com/global-lentiviral-vector-cdmo-market/

Contact:

Ruta Halde
Associate, Medi-Tech Insights
Phone: +32 498 86 80 79
Email: info@meditechinsights.com
Website: https://meditechinsights.com/

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vaccine CDMO Market: Key Developments in Biopharmaceutical Manufacturing to 2030 here

News-ID: 3946892 • Views:

More Releases from Medi-Tech Insights

Sterilization Equipment Market Shows Strong Investment Potential with 7-9% CAGR Forecast by 2029
Sterilization Equipment Market Shows Strong Investment Potential with 7-9% CAGR …
The global sterilization equipment market is set to experience significant growth, with an expected CAGR of 7-9% over the next 5 years. This growth is driven by increasing demand for sterilization in healthcare facilities, stringent infection control regulations, rising surgical procedures, necessity to curb hospital-acquired infections (HAIs), and advancements in sterilization technologies. Sterilization equipment plays a critical role in ensuring the safety and hygiene of medical instruments, devices, and environments. These
Global Biologics Market Set to Expand at 10-12% CAGR from 2024 to 2029: Medi-Tech Insights
Global Biologics Market Set to Expand at 10-12% CAGR from 2024 to 2029: Medi-Tec …
The global biologics market is set to witness a growth rate of 10-12% in the next 5 years. Rising prevalence of chronic diseases; continued advancements in biotechnology; growing investment in biopharmaceutical R&D; and growing strategic partnerships between biotech firms & larger pharmaceutical companies are some of the key factors driving the biologics market. Biologics are a class of medications derived from living organisms, including proteins, sugars, and nucleic acids among others.
Telemedicine Market to Grow at 16-18% CAGR By 2029, Fueled by Tech Advancements and Demand for Virtual Care
Telemedicine Market to Grow at 16-18% CAGR By 2029, Fueled by Tech Advancements …
The global telemedicine market is set to witness a robust growth rate of 16-18% over the next five years. This growth is driven by the increasing adoption of digital healthcare solutions, a rise in chronic disease prevalence, an aging population demanding more accessible care, technological advancements in telehealth platforms, growing government support, and the shift toward remote patient monitoring and virtual care solutions. Telemedicine refers to the remote diagnosis, treatment, and
High Flow Oxygen Therapy Market Set to Grow at 7% CAGR by 2029 Driven by Rising Respiratory Cases and Technological Advancements
High Flow Oxygen Therapy Market Set to Grow at 7% CAGR by 2029 Driven by Rising …
The high flow oxygen therapy (HFOT) market is growing at a projected compound annual growth rate (CAGR) of around 7% in the forecast period. Key drivers include the rising prevalence of respiratory diseases such as COPD, pneumonia, and acute respiratory failure, along with increased adoption of non-invasive treatments. Technological advancements in HFOT devices and the growing elderly population further support market growth. However, high device costs and limited reimbursement in

All 5 Releases


More Releases for CDMO

FDP CDMO Research: China FDP CDMO market size is projected to reach USD 1.33 bil …
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Fraud Detection and Prevention (FDP) System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the
Global Cmo And Cdmo Biotechnology Market Size by Application, Type, and Geograph …
According to Market Research Intellect, the global Cmo And Cdmo Biotechnology market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. Biologics and sophisticated medicines are driving the biotechnology industry for Contract Manufacturing Organizations (CMO) and Contract
Evolving Market Trends In The Inhalation CDMO Industry: Strategic Collaborations …
The Inhalation CDMO Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Inhalation CDMO Market Size During the Forecast Period? In recent times, the inhalation CDMO market has experienced significant growth. The market value is expected to increase from $2.08 billion in 2024
What's Driving the Inhalation CDMO Market 2025-2034: Rising Respiratory Disorder …
How Is the Chondroplasty Market Projected to Grow, and What Is Its Market Size? The chondroplasty market has seen strong growth in recent years. It will increase from $13.77 billion in 2024 to $14.68 billion in 2025 at a CAGR of 6.5%. This growth is attributed to the rise in sports-related injuries, patient preference for non-total joint replacement procedures, advances in postoperative care, healthcare provider training, and an increasing incidence of
Lentiviral Vector (LVV) CDMO Services Market Delivering Cures: The Role of LVV C …
Lentiviral Vector (LVV) CDMO Services Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Lentiviral Vector (LVV) CDMO Services Market - (By Type (IIT Grade, IND Grade, Clinical Trial Grade, Commercial Production Grade), By Application (Biopharmaceutical Company, Academic Scientific Research Institution)), Trends, Industry Competition Analysis, Revenue and Forecast To
Electronic Chemicals CDMO Market Fueling the Electronics Boom: The Rise of the E …
Electronic Chemicals CDMO Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Electronic Chemicals CDMO Market - (By Type (Metals and Pastes, Electronic Specialty Gases, Polymer Compounds, Others), By Application (Battery, Semiconductor, Integrated Circuit, Consumer Electronics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest